Active Ingredient History

NOW
  • Now
Enobosarm, also known as ostarine or MK-2866, is an investigational selective androgen receptor modulator (SARM) developed by GTx, Inc. for the treatment of conditions such as muscle wasting and osteoporosis, formerly under development by Merck & Company.   Wikipedia

  • SMILES: C[C@](O)(COc1ccc(cc1)C#N)C(=O)Nc2ccc(C#N)c(c2)C(F)(F)F
  • InChIKey: JNGVJMBLXIUVRD-SFHVURJKSA-N
  • Mol. Mass: 389.33
  • ALogP: 3.22
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
enobosarm | gtx 024 | gtx-024 | mk2866 | mk 2866 | mk-2866 | ostarine

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue